More news
Many countries requesting the COVID-19 vaccine use adenoviral vectors, none using the dual-vector platform developed through the Gamaleya Center, he said.
Follow us
By clicking “Accept all cookies”, you agree to the storage of cookies on your device to navigate the site, analyze site usage and assist us in our marketing efforts. Cookies policy.